Nicorandil tablets are indicated for the prevention and long term treatment of chronic stable angina pectoris, reduction in the risk of acute coronary syndromes in patients with chronic stable angina and at least one of the following risk factors: previous MI, Previous CABG, CHD on angiography or a positive exercise test together with one of the following: LVH on ECG, left ventricular dysfunction, Age ≥ 65, diabetes mellitus, hypertension or documented vascular disease.